{"id":16699,"date":"2018-07-23T02:50:36","date_gmt":"2018-07-23T02:50:36","guid":{"rendered":"http:\/\/thepatientinvestor.com\/?p=16699"},"modified":"2018-07-23T04:24:39","modified_gmt":"2018-07-23T04:24:39","slug":"pro-medicus-pme","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/","title":{"rendered":"Pro Medicus (PME)"},"content":{"rendered":"<p>Stock: <strong>Pro Medicus<\/strong><br \/>\nSymbol: <strong>PME<\/strong><br \/>\nExchange: ASX<br \/>\nFinancial Year-end: 30 June 2018<br \/>\nLatest price: $<strong>8.07<\/strong><br \/>\nDate: July 19, 2018<\/p>\n<h2>Company Profile<\/h2>\n<p>Pro Medicus Ltd provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions to\u00a0hospitals, imaging centres and health care groups worldwide.<\/p>\n<p>Its Visage product line comprises solutions for RIS (Radiology Information Systems) \/Practice Management, Healthcare Imaging and e-health. These systems can be used either individually or in combination by radiologists and other medical imaging professionals to interpret images created by medical imaging equipment such as X-Ray and Ultrasound machines and CT and MRI Scanners and communicate the results to their referring clinicians.<\/p>\n<p>The company has offices in Melbourne, Berlin and San Diego.<\/p>\n<h3>Competitors<\/h3>\n<p>About 70% of sales are in the USA where the company competes with big names like Siemens, Fuji and Phillips.<\/p>\n<p>Improving margins and big name contracts such as the Mayo Clinic in the US and Primary Health and I-Med in Australia suggest that the company is able to compete effectively.<\/p>\n<h3>Financial performance<\/h3>\n<h4>Margins<\/h4>\n<p>Operating margins declined from 2011 to 2013, along with revenues but have steadily recovered to 49.04 for the 12 months to 31 December 2017 (TTM).<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png?w=525&#038;ssl=1\" alt=\"PME Operating &amp; Net Income Margin % of Revenue\" \/><\/p>\n<p>Net income margin has recovered to a healthy 29% of revenue.<\/p>\n<h4>Revenue Growth<\/h4>\n<p>Revenue growth recovered, after falling 2011 &#8211; 2013, to average 14.7% compound growth since 2018. Annual growth in the range of 15% to 20% is expected.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/pme-revenue-eps.png?w=525&#038;ssl=1\" alt=\"PME Revenue &amp; Earnings per share\" \/><\/p>\n<p>From 31 Dec 2017 Directors Report: &#8220;&#8230;.the Company continued to make strong inroads into the North America market winning a key $18.0m contract with Yale New Haven Health, one of the most recognised health systems in North America.&#8221;<\/p>\n<p>The vast majority of the company\u2019s contracts are now transaction-based \u201cpay per view\u201d which increases the appeal to smaller practices and locks in future growth for the company as revenues grow in line with client revenues.<\/p>\n<h4>Earnings per share<\/h4>\n<p>Earnings per share is expected to grow faster than revenue due to improving margins and economies of scale.<\/p>\n<h4>Capital structure<\/h4>\n<p>Cash reserves were $22.80m at 31 December 2017 and the Company remains debt free.<\/p>\n<h3>Weaknesses<\/h3>\n<p>Future growth depends on the company&#8217;s ability to maintain its competitive position.<\/p>\n<p>International profits are also vulnerable to foreign exchange fluctuations.<\/p>\n<h2>Valuation<\/h2>\n<p>Price\/Earnings is high at 66.5 based on expected 2018 earnings of 12.1 cents. With a gross dividend yield of 0.62% that implies revenue growth at the top of the expected range (20%) while operating costs continue to grow at 8%.<\/p>\n<p>&nbsp;<\/p>\n<h2>Technical Analysis<\/h2>\n<p>Price peaked at $9.00 in January 2017 and has consolidated above support at $7.00. 50-Week Twiggs Momentum is again rising after a low of 67.3% in May 2018 backed up by 50-week Trend Index holding above zero since July 2012.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2018-07-19-pme.png?w=525&#038;ssl=1\" alt=\"PME Twiggs Momentum &amp; Trend Index\" \/><\/p>\n<p>On the daily chart, Twiggs Trend Index (21-day) flags a fresh entry point with a 0.2% upward reversal.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2018-07-19-pme-dy.png?w=525&#038;ssl=1\" alt=\"PME Twiggs Trend Index (21-day)\" \/><\/p>\n<h2>Conclusion<\/h2>\n<p>BUY (July 23, 2018)<\/p>\n<h4>Disclosure<\/h4>\n<p>Staff of The Patient Investor may directly or indirectly own shares in the above company.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stock: Pro Medicus Symbol: PME Exchange: ASX Financial Year-end: 30 June 2018 Latest price: $8.07 Date: July 19, 2018 Company Profile Pro Medicus Ltd provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions to\u00a0hospitals, imaging centres and health care groups worldwide. Its Visage product line comprises solutions for RIS &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pro Medicus (PME)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[40,3799,57],"tags":[3847,3846],"class_list":["post-16699","post","type-post","status-publish","format-standard","hentry","category-australia-nz-countries-regions","category-asx-growth","category-stock-markets","tag-pme","tag-pro-medicus"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pro Medicus (PME) - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pro Medicus (PME) - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Stock: Pro Medicus Symbol: PME Exchange: ASX Financial Year-end: 30 June 2018 Latest price: $8.07 Date: July 19, 2018 Company Profile Pro Medicus Ltd provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions to\u00a0hospitals, imaging centres and health care groups worldwide. Its Visage product line comprises solutions for RIS &hellip; Continue reading &quot;Pro Medicus (PME)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-23T02:50:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-07-23T04:24:39+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Pro Medicus (PME)\",\"datePublished\":\"2018-07-23T02:50:36+00:00\",\"dateModified\":\"2018-07-23T04:24:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/\"},\"wordCount\":460,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/pme-margin-ni-operating.png\",\"keywords\":[\"PME\",\"Pro Medicus\"],\"articleSection\":[\"Australia &amp; NZ\",\"Australian Growth\",\"Stock Markets\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/\",\"name\":\"Pro Medicus (PME) - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/pme-margin-ni-operating.png\",\"datePublished\":\"2018-07-23T02:50:36+00:00\",\"dateModified\":\"2018-07-23T04:24:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/pme-margin-ni-operating.png\",\"contentUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/pme-margin-ni-operating.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2018\\\/07\\\/23\\\/pro-medicus-pme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pro Medicus (PME)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\\\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/people\\\/The-Patient-Investor\\\/61572934660810\\\/\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\",\"https:\\\/\\\/au.linkedin.com\\\/in\\\/colintwiggs\"],\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/investor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pro Medicus (PME) - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Pro Medicus (PME) - the patient investor","og_description":"Stock: Pro Medicus Symbol: PME Exchange: ASX Financial Year-end: 30 June 2018 Latest price: $8.07 Date: July 19, 2018 Company Profile Pro Medicus Ltd provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions to\u00a0hospitals, imaging centres and health care groups worldwide. Its Visage product line comprises solutions for RIS &hellip; Continue reading \"Pro Medicus (PME)\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2018-07-23T02:50:36+00:00","article_modified_time":"2018-07-23T04:24:39+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Pro Medicus (PME)","datePublished":"2018-07-23T02:50:36+00:00","dateModified":"2018-07-23T04:24:39+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/"},"wordCount":460,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png","keywords":["PME","Pro Medicus"],"articleSection":["Australia &amp; NZ","Australian Growth","Stock Markets"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/","name":"Pro Medicus (PME) - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png","datePublished":"2018-07-23T02:50:36+00:00","dateModified":"2018-07-23T04:24:39+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/pme-margin-ni-operating.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/23\/pro-medicus-pme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Pro Medicus (PME)"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-4ll","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":36876,"url":"https:\/\/thepatientinvestor.com\/index.php\/2022\/08\/31\/pro-medicus-pme-2\/","url_meta":{"origin":16699,"position":0},"title":"Pro Medicus (PME)","author":"Colin Twiggs","date":"August 31, 2022","format":false,"excerpt":"Pro Medicus is an IT company specializing in radiology imaging software for the healthcare market. Its two main products are: Visage 7 clinical desktop application is used by radiologists to view, enhance, and manipulate images from any device and make diagnoses; and Visage RIS practice management software. Exponentially larger data\u2026","rel":"","context":"In &quot;Australian Growth&quot;","block_context":{"text":"Australian Growth","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/asx-growth\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":18869,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/16\/australian-growth-performance-at-31-august-2019\/","url_meta":{"origin":16699,"position":1},"title":"Australian Growth: Performance at 31 August 2019","author":"Andy","date":"September 16, 2019","format":false,"excerpt":"Australian Growth portfolio performance since inception on 1 July 2018 is set out below. This is too short a period to give a real indication as to how the portfolio will perform in the long-term: we expect to hold most growth stocks for 5 to 10 years. Performance of Individual\u2026","rel":"","context":"In &quot;Australian Growth Performance&quot;","block_context":{"text":"Australian Growth Performance","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/australian-growth-performance\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/09\/australian-performance-20190831.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":19622,"url":"https:\/\/thepatientinvestor.com\/index.php\/2020\/01\/15\/australian-growth-performance-at-31-december-2019\/","url_meta":{"origin":16699,"position":2},"title":"Australian Growth: Performance at 31 December 2019","author":"Andy","date":"January 15, 2020","format":false,"excerpt":"Australian Growth portfolio performance since inception on 1 July 2018 is set out below. This is too short a period to give a real indication as to how the portfolio will perform in the long-term: we expect to hold most growth stocks for 5 to 10 years. Performance of Individual\u2026","rel":"","context":"In &quot;Australian Growth Performance&quot;","block_context":{"text":"Australian Growth Performance","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/australian-growth-performance\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2020\/01\/australian-performance-bystock-20191231.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2020\/01\/australian-performance-bystock-20191231.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2020\/01\/australian-performance-bystock-20191231.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2020\/01\/australian-performance-bystock-20191231.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2020\/01\/australian-performance-bystock-20191231.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2020\/01\/australian-performance-bystock-20191231.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":19620,"url":"https:\/\/thepatientinvestor.com\/index.php\/2020\/01\/15\/asx-leading-sectors\/","url_meta":{"origin":16699,"position":3},"title":"ASX Leading Sectors","author":"Colin Twiggs","date":"January 15, 2020","format":false,"excerpt":"The ASX 200 broke resistance at 6800, signaling a fresh advance. Expect retracement to test the new support level. Respect would strengthen the bull signal, confirming a fresh advance. At the same time, fundamentals are distinctly bearish, with falling retail sales and dwindling GDP growth. So, what sectors are driving\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17458,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/02\/26\/australian-growth-portfolio-at-3-july-2018\/","url_meta":{"origin":16699,"position":4},"title":"Australian Growth &#8211; Portfolio at 3 July 2018","author":"Colin Twiggs","date":"February 26, 2019","format":false,"excerpt":"This is a model portfolio of Australian growth stocks selected by me on July 1st, 2018. The selection is based on my investment strategy and is more diverse than the International Growth portfolio, including stocks that generate strong dividend income and cyclical gold and resources stocks. Reasons for this are\u2026","rel":"","context":"In &quot;Australian Growth&quot;","block_context":{"text":"Australian Growth","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/asx-growth\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17884,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/02\/14\/australian-growth-pe-versus-growth\/","url_meta":{"origin":16699,"position":5},"title":"Australian Growth &#8211; PE versus Growth","author":"Colin Twiggs","date":"February 14, 2019","format":false,"excerpt":"I have plotted the stocks in our Australian Growth portfolio on a chart that compares the Forward Price-Earnings ratio against the Expected Growth Rate. The blue line on the chart below plots the P\/E, for each prospective growth rate, which matches a 12.5% annual rate of return. [To view a\u2026","rel":"","context":"In &quot;Australian Growth&quot;","block_context":{"text":"Australian Growth","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/asx-growth\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=16699"}],"version-history":[{"count":8,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16699\/revisions"}],"predecessor-version":[{"id":16716,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16699\/revisions\/16716"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=16699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=16699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=16699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}